von Willebrand Disease Panel with Collagen Binding Assay (CBA)
Test Code
Clinical Significance
von Willebrand Disease Panel with Collagen Binding Assay (CBA) -
This test may be used to help diagnose von Willebrand disease (VWD) and categorize disease subtype.
von Willebrand factor (VWF) is a blood coagulation protein that has 2 functions: (1) mediating platelet adhesion to the injured endothelium and (2) acting as a protective carrier protein for coagulation factor VIII. Deficiency of VWF causes VWD, the most common inherited bleeding disorder that affects approximately 1 in 1,000 individuals at the primary care level [1]. VWD is classified into type 1 (quantitative deficiency of VWF), type 2 (qualitative deficiency of VWF), and type 3 (total ...
Test Resources
Please visit our Clinical Education Center to stay informed on any future publications, webinars, or other education opportunities.
Test Details
Factor VIII Activity, Clotting
von Willebrand Factor Antigen
Ristocetin Cofactor
von Willebrand Factor Collagen Binding Assay
von Willebrand Antigen, Multimeric Analysis
Methodology
von Willebrand Antigen, Multimeric Analysis: This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Reference Range(s)
Alternative Name(s)
Preferred Specimen(s)
1 mL (x4) frozen platelet-poor plasma collected in 3.2% sodium citrate (light blue-top) tubes
Minimum Volume
0.75 mL (x4)
Collection Instructions
Please submit a separate, frozen vial for each special coagulation assay ordered. Draw blood in a light blue-top tube containing 3.2% sodium citrate, mix gently by inverting 3-4 times. Centrifuge 15 minutes at 1500 g within one hour of collection. Using a plastic pipette, remove plasma, taking care to avoid the WBC/platelet buffy layer and place into a plastic vial. Centrifuge a second time and transfer platelet-poor plasma into a new plastic vial(s). Freeze immediately and transport on dry ice.
Note: Storage of whole blood at refrigerated temperatures prior to processing may lead to cryoprecipitate formation and falsely low Factor ViII and von Willebrand Factor studies.
Transport Container
Transport tube(s)
Transport Temperature
Frozen
Specimen Stability
- Room temperature: Unacceptable
- Refrigerated: Unacceptable
- Frozen: 14 days
Reject Criteria
Received room temperature • Received refrigerated
Setup Schedule
Please submit a separate, frozen vial for each special coagulation assay ordered. Draw blood in a light blue-top tube containing 3.2% sodium citrate, mix gently by inverting 3-4 times. Centrifuge 15 minutes at 1500 g within one hour of collection. Using a plastic pipette, remove plasma, taking care to avoid the WBC/platelet buffy layer and place into a plastic vial. Centrifuge a second time and transfer platelet-poor plasma into a new plastic vial(s). Freeze immediately and transport on dry ice.
Note: Storage of whole blood at refrigerated temperatures prior to processing may lead to cryoprecipitate formation and falsely low Factor ViII and von Willebrand Factor studies.
Refrigerated: Unacceptable
Frozen: 14 days